Biomarkers

2.0k papers and 36.6k indexed citations i.

About

The 2.0k papers published in Biomarkers in the last decades have received a total of 36.6k indexed citations. Papers published in Biomarkers usually cover Molecular Biology (611 papers), Cancer Research (379 papers) and Health, Toxicology and Mutagenesis (364 papers) specifically the topics of Carcinogens and Genotoxicity Assessment (197 papers), Environmental Toxicology and Ecotoxicology (141 papers) and Air Quality and Health Impacts (99 papers). The most active scholars publishing in Biomarkers are Lúcia Guilhermino, Stephanie D. Teeter, Michael P. Gamcsik, O. Michael Colvin, Stephen M. Rappaport, Mohit S. Kasibhatla, Jeremy K. Nicholson, Peter J. Barnes, Sergei A. Kharitonov and Sandy Kennedy.

In The Last Decade

Fields of papers published in Biomarkers

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Biomarkers. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Biomarkers

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Biomarkers. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Biomarkers with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025